Government-Industry Partnership breaks ground on $50 million BioAccelerator
The BioAccelerator will support Canada’s rapidly expanding bioscience industry
Charlottetown, PE – Today, the Governments of Canada and Prince Edward Island broke ground on the BioAccelerator, a unique multi-function facility with 60,000 sq. ft. of biomanufacturing space that will provide facilities and services to researchers, entrepreneurs, and bioscience-based companies. The BioAccelerator is the largest single investment in economic development infrastructure in PEI history.
Spearheaded by the PEI BioAlliance, the BioAccelerator will provide essential biomanufacturing infrastructure to advance the bioscience and life sciences ecosystem regionally and nationally. The BioAccelerator will support the growth of the PEI bioscience cluster, enhance Canadian pandemic preparedness, and advance Atlantic Canada’s position as a national centre of expertise in bio-based product development and biomanufacturing.
“Prince Edward Island has become a real leader in Canada’s bioscience network,” said the Honourable Lawrence MacAulay, Minister of Agriculture and Agri-Food and Member of Parliament for Cardigan, on behalf of Gudie Hutchings, Minister of Rural Economic Development and Minister responsible for the Atlantic Canada Opportunities Agency. “The new BioAccelerator facility will create much-needed capacity to help this important sector reach its full potential and I’m so pleased that our government is supporting the next phase of growth.”
Located in the BioCommons Research Park in Charlottetown, the BioAccelerator builds upon recent public and private sector investments such as BIOVECTRA’s first-in-Canada mRNA vaccine manufacturing facility, the Canadian Alliance for Skills and Training in Life Sciences (CASTL), and the Bioscience Manufacturing Incubator.
Tenants in the BioAccelerator will include early-stage and small and medium-sized enterprises from Atlantic Canada and international locations. The BioAccelerator will host the facilities and expertise of the National Research Council of Canada’s atypical fermentation labs, CASTL’s national headquarters, and an expanded lead training facility. CASTL provides hands-on biopharmaceutical manufacturing training for the talent pipeline essential to Canada’s Biomanufacturing and Life Sciences Strategy, including pandemic response.
“The BioAccelerator speaks to the strength of collaboration between government and industry, and to what we can achieve when we share a vision of PEI as a place of possibility and prosperity,” said Hon. Dennis King, Premier of Prince Edward Island. “It is a proud moment to see the progress being made to get this state-of-the-art facility off the ground.”
PEI’s bioscience community is recognized nationally and internationally for its collaborative economic cluster model that drives innovation and sector growth. Through the aligned efforts of business, academia, research, and government partners, the sector now includes 60 bioscience companies earning over $600 million annually in sales, making bioscience the second-largest industry in Prince Edward Island. The PEI Bioscience Cluster has surpassed 2025 growth targets and is well on its way to becoming a billion-dollar industry by 2030.
“Prince Edward Island companies and research organizations have put our province on the map for our expertise in bio-manufacturing, from mRNA vaccines, to natural health products, to fish health and nutrition. The BioAccelerator will be an incredible addition to that capability,” said Charmaine Noonan, Board Chair, PEI BioAlliance and Senior Director, Merck Animal Health PEI.
“It is gratifying to see the outstanding support of our federal and provincial partners for the bioscience sector and today more specifically for this BioAccelerator project,” said Rory Francis, CEO of the PEI BioAlliance. “Our goal is to provide a positive return on this investment for PEI, for the Atlantic Region, and for all of Canada.”
The BioAccelerator will be operated by the PEI BioAlliance. Construction of the BioAccelerator is expected to be completed in the fall of 2026.
Media Contact
Jenny Dunne
Manager, Communications and Marketing
PEI BioAlliance